State Of Wisconsin Investment Board Fate Therapeutics Inc Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.76 - $6.59 $320,814 - $444,152	-67,398 Reduced 35.97%	119,987 $571,000
Q1 2023 May 15, 2023	BUY	$4.24 - $11.12 $393,382 - $1.03 Million	92,779 Added 98.07%	187,385 $1.07 Million
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $154,693 - $373,868	15,689 Added 19.88%	94,606 $954,000
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $81,424 - $139,552	-3,870 Reduced 4.67%	78,917 $1.77 Million
Q2 2022 Aug 15, 2022	SELL	$17.78 - $42.39 $460,733 - $1.1 Million	-25,913 Reduced 23.84%	82,787 $2.05 Million
Q4 2021 Feb 11, 2022	BUY	$47.84 - $64.34 $296,608 - $398,908	6,200 Added 6.05%	108,700 $6.36 Million
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $226,944 - $366,550	-3,829 Reduced 3.6%	102,500 $6.08 Million
Q2 2021 Aug 12, 2021	SELL	$67.25 - $92.52 $18,224 - $25,072	-271 Reduced 0.25%	106,329 $9.23 Million
Q1 2021 May 17, 2021	BUY	$72.16 - $117.4 $180,400 - $293,500	2,500 Added 2.4%	106,600 $8.79 Million
Q4 2020 Feb 03, 2021	BUY	$38.09 - $100.95 $137,124 - $363,420	3,600 Added 3.58%	104,100 $9.47 Million
Q2 2020 Aug 12, 2020	BUY	$20.21 - $35.23 $139,449 - $243,086	6,900 Added 7.37%	100,500 $3.45 Million
Q1 2020 May 06, 2020	BUY	$17.28 - $31.88 $79,488 - $146,648	4,600 Added 5.17%	93,600 $2.08 Million
Q2 2019 Aug 14, 2019	BUY	$15.61 - $20.44 $31,220 - $40,880	2,000 Added 2.3%	89,000 $1.81 Million
Q1 2019 May 13, 2019	BUY	$13.15 - $18.71 $461,565 - $656,721	35,100 Added 67.63%	87,000 $1.53 Million
Q4 2018 Feb 11, 2019	BUY	$11.48 - $16.98 $14,924 - $22,074	1,300 Added 2.57%	51,900 $666,000
Q2 2018 Aug 03, 2018	BUY	$9.16 - $13.48 $188,696 - $277,688	20,600 Added 68.67%	50,600 $574,000
Q3 2017 Nov 01, 2017	BUY	$2.6 - $4.31 $78,000 - $129,299	30,000	30,000 $119,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$29.2 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$23.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$22.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$12.4 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$11.7 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account